Circadia Health

Circadia Health builds contactless patient monitoring and predictive care tools for post-acute care, combining radar sensing hardware, machine learning and clinical software to detect early signs of medical events and reduce rehospitalisations. The company's technical work spans radar-based vital signs capture, AI-driven predictive analytics, hardware engineering and clinical software platforms, with all components developed in-house by a multidisciplinary team of engineers, scientists and physicians.

The Circadia platform is described as the world's first FDA-cleared contactless patient monitoring system. Its C200 device uses radar to measure vital signs without touching the patient and is designed to surface early indicators of conditions including heart failure, pneumonia and sepsis. Monitoring data feeds a Clinical Intelligence Platform that converts it into clinical insights, supported by care coordination services that close the loop on delivery.

Reported scale figures include more than 30,000 patients monitored daily and a 30% reduction in rehospitalisations after 12 months. The company operates across post-acute care, hospitals and clinician care delivery, with a stated emphasis on asking the right questions, solving the right problems and challenging established practice in order to establish a new standard of care.